Intervention Protocol

Asenapine versus typical antipsychotics for schizophrenia

  1. Ajit Kumar1,*,
  2. Manoj Narayan2,
  3. Haroon Raja3,
  4. Manoj J Mathen4

Editorial Group: Cochrane Schizophrenia Group

Published Online: 14 NOV 2012

DOI: 10.1002/14651858.CD010230


How to Cite

Kumar A, Narayan M, Raja H, Mathen MJ. Asenapine versus typical antipsychotics for schizophrenia (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No.: CD010230. DOI: 10.1002/14651858.CD010230.

Author Information

  1. 1

    Leeds and York Partnership NHS Foundation Trust, Psychiatry, Leeds, UK

  2. 2

    Leeds and York Partnerships NHS Foundation Trust, Psychiatry of Learning Disability, York, UK

  3. 3

    South West Yorkshire Partnerships NHS Foundation Trust, General Adult Psychiatry, Wakefield, UK

  4. 4

    Leeds and York Partnership NHS Foundation Trust, General Adult Psychiatry, Leeds, UK

*Ajit Kumar, Psychiatry, Leeds and York Partnership NHS Foundation Trust, Linden House, St Mary's Hospital, Green Hill Road, Leeds, LS12 3QE, UK. ajitkdrmr@yahoo.com.

Publication History

  1. Publication Status: New
  2. Published Online: 14 NOV 2012

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To review the efficacy of asenapine compared with other typical antipsychotic drugs for people with schizophrenia.